About five out of every 100 people with Sjögren’s disease may experience serious cardiovascular events over nearly 10 years of follow-up, and these events are linked to a higher risk of death of any cause, a study in Spain shows. In addition to traditional cardiovascular risk factors, disease-specific factors…
Discussion
More than half of people with Sjögren’s disease have high levels of an inflammatory protein called interferon-alpha (IFN-alpha) and a distinct pattern of immune system dysregulation, according to data from people living in the U.K. Study findings suggest that IFN-alpha may be a critical marker to distinguish between different…
Discussion
People around the world are gearing up to observe World Sjögren’s Day, an annual campaign dedicated to raising awareness and understanding of Sjögren’s disease, a chronic autoimmune disorder that affects millions of people worldwide. Created by the Sjögren’s Foundation in 2005, World Sjögren’s Day is observed each year on…
Discussion
Innovent Biologics, a China-based biopharmaceutical company, is planning to launch a Phase 2 clinical trial testing its experimental therapy IBI355 in people with Sjögren’s disease. The study will be conducted in China and is expected to launch in early 2027, according to a press release from Innovent…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
